1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
Follow Myelosuppression: new trials by email Literature Review of Myelosuppression trials Research Report on Myelosuppression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III, Randomized, Double-blind, Multi-center Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer Trilaciclib, Trilaciclib Placebo, Etoposide Injection - Myelosuppression | Phase 3 | Active not recruiting | Jiangsu Simcere Pharmaceutical Co., Ltd. | 106 | 2026-06-17 | 2026-10-19 |
| A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC 5-fu, Lobaplatin, Placebo - Nasopharyngeal Carcinoma, Leucogen | Phase 3 | Not yet recruiting | Sun Yat-sen University | 132 | 2023-04-01 | 2023-03-22 |
| Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma platelet transfusion - Hemato-Oncologic Patients, Myelosuppression | Phase 3 | Completed | Sanquin Research & Blood Bank Divisions | 180 | 2003-10-01 | 2007-02-27 |
Nasopharyngeal Carcinoma (1) · Small Cell Lung Carcinoma (1) · Thrombocytopenia (1) · Transfusion Reaction (1)
Neoplasms (2) · Neoplasms by Site (2) · Blood Platelet Disorders (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Cytopenia (1) · Head and Neck Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Neoplasms (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1)
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Fluorouracil (1) · Leyk (1) · Platelet Transfusion (1) · Radiotherapy (1) · lobaplatin (1) · trilaciclib (1)
Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Sanquin Research & Blood Bank Divisions (1) · Sun Yat-sen University (1)
China (2) · Netherlands (1)